Ping Gao

Mrs. Ping Gao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2011 in The Journal of Antibiotics
Verified
Journal Article
Closed access
PGPing Gao
Ping Gao
XNXin Nie
Xin Nie
MZMeijuan Zou
Meijuan Zou
YSYijie Shi
Yijie Shi
GCGang Cheng
Gang Cheng

1 February 2013 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
JRJungang Ren
Jungang Ren
MZMeijuan Zou
Meijuan Zou
PGPing Gao
Ping Gao
YWYue Wang
Yue Wang
GCGang Cheng
Gang Cheng

21 December 2015 in The Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
HZHuanian Zhang
Huanian Zhang
YWYang Wang
Yang Wang
PGPing Gao
Ping Gao
JHJiasheng Hu
Jiasheng Hu
YCYujun Chen
Yujun Chen
QXQiong Xu
Qiong Xu

1 February 2015 in International Immunopharmacology
Verified
Journal Article
Closed access
CZChengliang Zhang
Chengliang Zhang
YXYanjiao Xu
Yanjiao Xu
PGPing Gao
Ping Gao
JLJingli Lu
Jingli Lu
XLXiping Li
Xiping Li
DLDong Liu
Dong Liu

28 December 2012 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
CZChengliang Zhang
Chengliang Zhang
PGPing Gao
Ping Gao
WYWeifeng Yin
Weifeng Yin
YXYanjiao Xu
Yanjiao Xu
DXDaochun Xiang
Daochun Xiang
DLDong Liu
Dong Liu

4 February 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
PGPing Gao
Ping Gao
XCXinwei Cheng
Xinwei Cheng
MLMaochang Liu
Maochang Liu
HPHui Peng
Hui Peng
GLGuodong Li
Guodong Li
CZChengliang Zhang
Chengliang Zhang
Tacrolimus-induced chronic nephrotoxicity (TICN) hinders long-term use of tacrolimus, but its mechanism remains unclear. Tacrolimus exerts its pharmacological effect by inhibiting calcineurin and its substrate nuclear factor of activated T cells. Whether the inhibition of other calcineurin substrates is related to TICN remains to be explored. Transcription factor EB (TFEB), a substrate of calcineurin, plays a crucial role in homeostasis. Herein, we found that tacrolimus inhibited TFEB nuclear translocation and activity in mouse kidneys and HK-2 cells. Then, TFEB gain and loss of function rescued and exacerbated, respectively, the effect of tacrolimus in HK-2 cells. Furthermore, TFEB activation by both phosphorylation site mutation and agonist rescued TICN in mice. To elucidate the mechanism of TFEB, we analyzed ChIP-Seq data. We identified growth arrest and DNA damage-inducible 45α (GADD45α) as a transcriptional target of TFEB via ChIP and dual-luciferase reporter assays. Then we revealed that GADD45α overexpression rescued DNA damage and kidney injury caused by tacrolimus or TFEB knockdown in vitro and vice versa. The protective effect of GADD45α against TICN and DNA damage was further demonstrated by overexpressing it in mice. In conclusion, the persistent inhibition of the TFEB/GADD45α pathway by tacrolimus contributes to TICN. This study identifies a specific target for intervention in TICN.